Literature DB >> 25011467

Pathology or normal variant: what constitutes a delay in puberty?

Carine Villanueva1, Jesús Argente.   

Abstract

Puberty is a complex maturation process that begins during fetal life and persists until the acquisition of reproduction function. The fundamental event that activates puberty occurs in the hypothalamus. A complex neuron network stimulates GnRH secretion, which stimulates pituitary gonadotropin secretion and then gonadal steroid secretion. Pubertal delay is defined as the presentation of clinical signs of puberty 2-2.5 SD later than in the normal population. Three major groups of etiopathogeneses are described: (1) hypogonadotropic hypogonadism, (2) hypergonadotropic hypogonadism, and (3) constitutional delay of puberty (CDP) - the most common cause of delayed puberty in boys. The differential diagnosis between CDP and isolated hypogonadotropic hypogonadism remains difficult. Mechanisms of pubertal timing are now better understood and genetic or epigenetic causes can explain some pubertal delays. However, there are still unexplained mechanisms. Treatment of delayed puberty is necessary to ensure full pubertal development for the adolescent and in case of hypogonadism, to restore fertility. Finally, precocious diagnosis of hypogonadism is primordial but can be difficult during childhood and in cases of partial hypogonadism. The study of genetic pubertal diseases or of different animal models could help to discover new diagnostic or therapeutic tools.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25011467     DOI: 10.1159/000362600

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  3 in total

1.  Use of testosterone gel compared to intramuscular formulation for puberty induction in males with constitutional delay of growth and puberty: a preliminary study.

Authors:  Laura Chioma; Giulia Papucci; Danilo Fintini; Marco Cappa
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

2.  Efficacy of short-term induction therapy with low-dose testosterone as a diagnostic tool in the workup of delayed growth and puberty in boys.

Authors:  T Todisco; S Mastromattei; L Chioma; G Ubertini; M G Pattumelli; D Fintini; M Cappa
Journal:  J Endocrinol Invest       Date:  2022-07-28       Impact factor: 5.467

3.  The Effects of Benoxacor on the Liver and Gut Microbiome of C57BL/6 Mice.

Authors:  Derek Simonsen; Nicole Cady; Chunyun Zhang; Rachel L Shrode; Michael L McCormick; Douglas R Spitz; Michael S Chimenti; Kai Wang; Ashutosh Mangalam; Hans-Joachim Lehmler
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.